Loading

FDA Townhall

June 04, 2024
Special Program
Regulatory Innovation
25ABC
Join us for a moderated discussion with the directors of the Center for Drug Evaluation and Research (CDER) and the Center for Biologics Evaluation and Research (CBER) of the U.S. Food and Drug Administration (FDA). Topics will include center priorities, staffing, and key initiatives.
Speakers
Steve Berman
Deputy Vice President, Science and Regulatory Affairs Strategy
Biotechnology Innovation Organization (BIO)
Speakers
Patrizia Cavazzoni, MD
Director, Center for Drug Evaluation and Research
FDA
Peter Marks, MD, PhD
Director, Center for Biologics Evaluation and Research (CBER)
U.S. Food and Drug Administration
Back to Session List

BIO DOUBLE HELIX SPONSOR

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

Loading

BIO HELIX SPONSORS